Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-14 (N.D.W.Va. Mar. 18, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-14 (N.D.W.Va. Mar. 18, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-6 (N.D.W.Va. Mar. 18, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-6 (N.D.W.Va. Mar. 18, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-1 (N.D.W.Va. Mar. 18, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-1 (N.D.W.Va. Mar. 18, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-9 (N.D.W.Va. Mar. 18, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-9 (N.D.W.Va. Mar. 18, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-12 (N.D.W.Va. Mar. 18, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-12 (N.D.W.Va. Mar. 18, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-2 (N.D.W.Va. Mar. 18, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-2 (N.D.W.Va. Mar. 18, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-3 (N.D.W.Va. Mar. 18, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-3 (N.D.W.Va. Mar. 18, 2022)
+ More Snippets
Document
IPR2022-00657, No. 13 Exhibit List - Patent Owner Updated Exhibit List (P.T.A.B. Sep. 7, 2022)
Cite Document
IPR2022-00657, No. 13 Exhibit List - Patent Owner Updated Exhibit List (P.T.A.B. Sep. 7, 2022)
+ More Snippets
Docket
209637,
Orange Book
(Dec. 5, 2017)
Cite Docket
OZEMPIC, 209637 (Orange Book)
+ More Snippets
Document
IPR2020-00324, No. 12 Order - DECISIONGranting Patent Owner¿¿¿s Unopposed Motions for Pro Hac Vice Admission of Laura T Moran and Ryan P Johnson37 CFR sec 4210c (P.T.A.B. Jun. 23,...
Cite Document
IPR2020-00324, No. 12 Order - DECISIONGranting Patent Owner¿¿¿s Unopposed Motions for Pro Hac Vice Admission of Laura T Moran and Ryan P Johnson37 CFR sec 4210c (P.T.A.B. Jun. 23, 2020)
+ More Snippets
Document
IPR2020-00324, No. 15 Order - Scheduling Order (P.T.A.B. Jun. 23, 2020)
Cite Document
IPR2020-00324, No. 15 Order - Scheduling Order (P.T.A.B. Jun. 23, 2020)
+ More Snippets
Document
IPR2020-00324, No. 13 Institution Decision - Trial Instituted Document (P.T.A.B. Jun. 23, 2020)
Cite Document
IPR2020-00324, No. 13 Institution Decision - Trial Instituted Document (P.T.A.B. Jun. 23, 2020)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-6 (N.D.W.Va. May. 11, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-6 (N.D.W.Va. May. 11, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-7 (N.D.W.Va. May. 11, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-7 (N.D.W.Va. May. 11, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-5 (N.D.W.Va. May. 11, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-5 (N.D.W.Va. May. 11, 2022)
+ More Snippets